U.S. markets closed
  • S&P Futures

    +1.50 (+0.04%)
  • Dow Futures

    +9.00 (+0.03%)
  • Nasdaq Futures

    -5.00 (-0.04%)
  • Russell 2000 Futures

    +1.40 (+0.09%)
  • Crude Oil

    -0.24 (-0.61%)
  • Gold

    -1.40 (-0.07%)
  • Silver

    -0.07 (-0.27%)

    +0.0001 (+0.01%)
  • 10-Yr Bond

    -0.0180 (-2.71%)
  • Vix

    +0.08 (+0.31%)

    -0.0006 (-0.05%)

    +0.1160 (+0.11%)

    -13.92 (-0.13%)
  • CMC Crypto 200

    -6.76 (-2.95%)
  • FTSE 100

    -30.43 (-0.51%)
  • Nikkei 225

    -80.18 (-0.34%)

Today’s Research Reports on Stocks to Watch: Texas Instruments and Precipio

NEW YORK, NY / ACCESSWIRE / July 19, 2018 / Texas Instruments Incorporated closed down modestly on Wednesday. The company's CEO Brian Crutcher recently resigned for violating conduct and in his place, former CEO Rich Templeton has taken his position. Shares of Precipio saw big gains after announcing preliminary second quarter results.

RDI Initiates Coverage on:

Texas Instruments Incorporated

Precipio, Inc.

Texas Instruments Incorporated shares closed down a modest 0.10% on Wednesday with almost 5.5 million shares traded. The company's CEO Brian Crutcher resigned from his roles at the company after violating the company's code of conduct. There was no description of what Crutcher did, but the company did say that his actions are "not consistent with its ethics and core values." The company has brought back its previous CEO, Rich Templeton. Mark Blinn, lead director of the company's Board, stated, "For decades, our company's core values and code of conduct have been foundational to how we operate and behave, and we have no tolerance for violations of our code of conduct. Over the past 14 years, Rich has successfully led TI to become the company it is today, and we have great confidence in his values and ability to continue to lead this company forward." Separately, while the company is scheduled to post full second-quarter financial results on July 24, the company reported adjusted second-quarter earnings of $1.37 a share on $4.02 billion in revenue.

Access RDI's Texas Instruments Incorporated Research Report at:

Precipio, Inc. shares closed up 30.90% on about 33.6 million shares traded on Wednesday. The specialty cancer diagnostics company saw a big pop in its share prices after announcing preliminary second quarter results. Precipio reported that on a preliminary basis, revenue for the second quarter is expected to be $815,000, up from $260,000 in the second quarter of 2017. This will represent a growth of 213%. In the fourth quarter of 2017, year over year growth was 199%. For the fourth quarter of 2018, the number was 187%. Precipio also said that revenue for the first half of 2018 is estimated at $1.5M. This is three times compared to the $0.5M in the first half of 2017. CEO Ilan Danieli remarked, "These results represent further validation of our high growth strategy to rapidly gain pathology services market share, and commercialize our unique liquid biopsy, mutation detection products for cancer. We are confident with the potential effect on market and enterprise value resulting from this trend, as we continue to hit revenue and commercialization milestones."

Access RDI's Precipio, Inc. Research Report at:

Our Actionable Research on Texas Instruments Incorporated (NASDAQ: TXN) and Precipio, Inc. (NASDAQ: PRPO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.


For any questions, inquiries, or comments reach out to us directly at:




CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com